BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Melo HN, Stoots SJ, Pool MA, Carvalho VO, Almeida LOC, Aragão MLC, Agyemang C, Cipolotti R. Physical activity level and performance in the six-minute walk test of children and adolescents with sickle cell anemia. Rev Bras Hematol Hemoter 2017;39:133-9. [PMID: 28577650 DOI: 10.1016/j.bjhh.2017.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Vohr BR, Heyne R, Bann CM, Das A, Higgins RD, Hintz SR; Eunice Kennedy Shriver National Institute of Child Health, and Development Neonatal Research Network. Extreme Preterm Infant Rates of Overweight and Obesity at School Age in the SUPPORT Neuroimaging and Neurodevelopmental Outcomes Cohort. J Pediatr 2018;200:132-139.e3. [PMID: 29793869 DOI: 10.1016/j.jpeds.2018.04.073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
2 Gouraud E, Connes P, Gauthier-Vasserot A, Faes C, Merazga S, Poutrel S, Renoux C, Boisson C, Joly P, Bertrand Y, Hot A, Cannas G, Hautier C. Is Skeletal Muscle Dysfunction a Limiting Factor of Exercise Functional Capacity in Patients with Sickle Cell Disease? J Clin Med 2021;10:2250. [PMID: 34067352 DOI: 10.3390/jcm10112250] [Reference Citation Analysis]
3 Brownell JN, Schall JI, Mcanlis CR, Smith-Whitley K, Norris CF, Stallings VA. Effect of High-dose Vitamin A Supplementation in Children With Sickle Cell Disease: A Randomized, Double-blind, Dose-finding Pilot Study. J Pediatr Hematol Oncol 2020;42:83-91. [PMID: 31764511 DOI: 10.1097/MPH.0000000000001673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kuhn B, Moussalle LD, Lukrafka JL, Penna GB, Soares Júnior AO. Evaluation of the functional capacity and quality of life of children and adolescents during and after cancer treatment. Rev Paul Pediatr 2021;40:e2020127. [PMID: 34495268 DOI: 10.1590/1984-0462/2022/40/2020127] [Reference Citation Analysis]
5 Kweka BV, Fredrick C, Kitilya B, Jeremiah K, Lyimo E, Filteau S, Rehman AM, Friis H, Olsen MF, Faurholt-Jepsen D, Krogh-Madsen R, PrayGod G. Association of sickle cell trait with β-cell dysfunction and physical activity in adults living with and without HIV in Tanzania. APMIS 2022;130:230-9. [PMID: 35167170 DOI: 10.1111/apm.13214] [Reference Citation Analysis]
6 Farrell AT, Panepinto J, Desai AA, Kassim AA, Lebensburger J, Walters MC, Bauer DE, Blaylark RM, DiMichele DM, Gladwin MT, Green NS, Hassell K, Kato GJ, Klings ES, Kohn DB, Krishnamurti L, Little J, Makani J, Malik P, McGann PT, Minniti C, Morris CR, Odame I, Oneal PA, Setse R, Sharma P, Shenoy S. End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. Blood Adv 2019;3:4002-20. [PMID: 31809537 DOI: 10.1182/bloodadvances.2019000883] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
7 Marchese V, Rock K, Harpold A, Salazar A, Williams M, Shipper AG. Physical Impairment and Function in Children and Adolescents With Sickle Cell Disease: A Systematic Review. Arch Phys Med Rehabil 2021:S0003-9993(21)01443-X. [PMID: 34592159 DOI: 10.1016/j.apmr.2021.08.022] [Reference Citation Analysis]